Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high1,110.0 22/08/17
52 week low627.5 25/08/16
52 week change 462.5 (72.44%)
4 week volume5,574,355 27/07/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Form 8.3 - Clinigen Group plc

Form 8.3 - Clinigen Group plc Grandeur Peak Global Advisors, LLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Grandeur Peak ...

Form 8.3 - Clinigen Group

RNS Number: 7051O GVQ Investment Management Ltd 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: GVQ Investm...

Form 8.3 - Clinigen Group Plc

Form 8.3 - Clinigen Group Plc OBERWEIS ASSET FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Oberweis Asset Management, Inc...

Form 8.3 - Clinigen Group plc

RNS Number: 6917O BlackRock Group 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: BlackRock, Inc. (b) Owner or ...

Form 8.3 - Quantum Pharma plc

RNS Number: 6893O FIL Limited 22 August 2017 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: FMR LLC and/or one or more of it...

Form 8.5 (EPT/RI) - Clinigen Group Plc

RNS Number: 6312O Numis Securities Limited 22 August 2017 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Name of exempt principal trad...

Form 8.3 - Clinigen Group plc

Form 8.3 - Clinigen Group plc Grandeur Peak Global Advisors, LLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Grandeur Peak ...

Form 8.3 - Clinigen Group plc

Form 8.3 - Clinigen Group plc Grandeur Peak Global Advisors, LLC FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the ?Code?) 1. KEY INFORMATION (a) Full name of discloser: ? Grandeur Peak ...

Fundamental DataMore

P/E ratio92.521
EPS11.9
Dividend yield0.363 %

Equity Research (CLIN)

Clinigen Group Plc
16/03/2017
Magnolia Petroleum (MAGP.L) 0.14p £2.45m US onshore focused oil and gas exploration and production company, announced the results of an independent Reserves Report.  The Report, which is part of the...
edison investment research
Clinigen Group Plc
01/03/2016
Edison Investment Research is terminating coverage on Clinigen Group (CLIN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be...
edison investment research
Clinigen Group Plc
25/01/2016
Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to H2. The integration of Idis and Link, which we expect to boost its...

Latest discussion posts More

  • Cuurent Price

    With the price increasing toward the #11 recently due to the purchasing of Quantum Pharma I have decided to sell my shares today after several years of holding. I feel the ...
    21-Aug-2017
    bushwhacker
  • Re: Quantum Pharma

    From MoneyAM: Quantum Pharma plc is a growing manufacturer, supplier and service provider within the pharmaceutical sector. It is a market leader (in terms of its size or ...
    16-Aug-2017
    MaX ProfOrdiS
  • Quantum Pharma

    Does anyone know anything about Quantum Pharma? Clinigien proposed bid for the comapnay
    16-Aug-2017
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
LLOYDS GRP.20%
GLAXOSMITHKLINE19%
TELFORD HOMES18%
BP17%
RDS 'B'17%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN